Position in LQDA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$48,360,867
+$40,539,744 QoQ
Shares Held
606,558
+192.7% QoQ
Ownership
0.678%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#22
of 334 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Derivatives in LQDA
reported options exposure · as of Mar 31, 2024CallValue
$2,212,500
CallShares
150,000
PutValue
$737,500
PutShares
50,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. LQDA ranks #10 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,643,241 | $261,803,294 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
9,910,822 | $243,905,327 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
220,616 | $119,536,366 | |
| 4 | VTRS |
Viatris Inc
|
6,092,296 | $96,745,659 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
835,494 | $92,689,703 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
2,660,810 | $92,250,281 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
545,937 | $92,012,220 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,140,065 | $72,505,400 |
All Filings in LQDA
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,360,867 | 606,558 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $7,821,123 | 207,237 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $3,854,669 | 111,762 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $9,377,519 | 412,380 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,422,113 | 274,648 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,059,414 | 207,418 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,378,964 | 287,327 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $626,570 | 62,657 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,219,524 | 101,627 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,214,175 | 82,317 | Shares | Defined | 2024-05-13 | |
| 2024-03-31 | $2,212,500 | 150,000 | Call | Defined | 2024-05-13 | |
| 2024-03-31 | $737,500 | 50,000 | Put | Defined | 2024-05-13 | |
| 2023-12-31 | $676,567 | 56,240 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $156,381 | 24,666 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $268,634 | 34,221 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $234,069 | 33,874 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $168,995 | 26,530 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $95,346 | 17,527 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $34,653 | 7,948 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $24,383 | 3,396 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $28,016 | 10,151 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $9,506 | 3,324 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $36,366 | 13,519 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $13,393 | 4,540 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,774 | 564 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $54,401 | 6,461 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $36,822 | 7,818 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||